TRADING UPDATES: Unicorn Mineral; Helix Exploration agree acquisitions
8th Jun 2026 15:59
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on xxxday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on xxxday and not separately reported by Alliance News: Read More
Verici Dx PLC - Cardiff, Wales-based developer of advanced clinical diagnostics for organ transplants - Announces the publication of a peer-reviewed clinical validation study of its pre-transplant rejection assessment test, which is commercially marketed by Thermo Fisher Scientific Inc. Says the test outperformed conventional risk assessment tools in the ability to predict early acute rejection in the first two months following a kidney transplant, which enables clinicians to identify patients who may benefit from the safe minimisation of therapy while effectively managing the risk of early rejection. Says current methods, which involve standardised immunosuppressive regimens with more aggressive therapy for patients seen as high-risk, "have limited predictive value, which can lead to unnecessary over-suppression and risks related to toxicity, infections and malignancy." Read More
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Verici Dx PLC - Cardiff, Wales-based developer of advanced clinical diagnostics for organ transplants - Completes second biennial inspection of its clinical laboratory, accredited by the College of American Pathologists. Verici says the inspection, passed with no deficiencies, shows its "commitment to compliance and maintaining excellence in daily clinical laboratory operations according to CAP requirements". Adds: "By continuing to follow these strict CAP guidelines and pass CAP accreditation audits, Verici Dx can consistently provide reliable test results under its quality management system and further improve patient health." Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Verici Dx PLC - Cardiff, Wales-based developer of advanced clinical diagnostics for organ transplants - Reports "positive progress" in its plans to drive sales growth for Tutivia, its flagship kidney transplant diagnostic test. Says commercial scale-up of Tutivia test adoption has progressed in the third quarter with ordering clinicians rising 19%. Verici has also onboarded nine new transplant centres, bringing the total to 30 centres which represent 16% of annual transplants in the US. Says orders in the third quarter were consistent with the previous two, and expects volume growth in the fourth. Company also says it has expanded its commercial team with three new senior sales hires; a new director of clinical partnerships joins in mid-October; and Aubrey Powell joins the board as a non-executive director with Mount Sinai representative Erik Lium stepping down. The firm continues "to target meeting expectations" for its full-year 2025 results. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More
(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Stock prices in London edged higher at midday in London, shaking off early losses and the threat of a US government shutdown, as investors digested a broad slate of earnings releases. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More
(Alliance News) - European equities were muted at the market open on Monday, beaten by the FTSE 100 as the index passed the 9,000 mark on a boost from miners. Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More